Aerial view of part of the existing cell industrial park in the Shanghai's Zhangjiang Science City [Photo/WeChat account: zjpark]

A park with a whole chain of cell therapy-related facilitiesis to be constructed in Shanghai's Zhangjiang Science City, according to an official announcement made during the ChinaBio Partnering Forum held on May 8.

The park will integrate storage, R&D, production, transportation, treatment and mature equipment and is planned to become the core area of China's cell industry and a world-class cell industry science and technology innovation center by 2030 with a total output value exceeding 50 billion yuan ($7.35 billion).

Besides the cell industrial park, Zhangjiang also plans to form a cluster of the life and health industry covering the core park of Zhangjiang Pharma Valley, the medical instrument park and the international medical park, according to Yuan Tao, chairman of Zhangjiang Group.

Zhangjiang has many advantages in the cell therapy industry. According to incomplete statistics, it currently has more than 50 enterprises related to cell therapy, and the first new domestic cell therapy drug independently developed in Zhangjiang is expected to come to the market as soon as next year.